Gain 3+ lines of visual acuity at 1 year · macular edema in diabetes
Intravitreal dexamethasone implant 0.7 mg may leads to lower gain of three or more lines visual acuity ‐ 12 months compared with intravitreal antiVEGF (low certainty).
1 finding from 1 review
RR 0.99
Studies not reported
Low
Number of people incurring one or more complications requiring substantive treatment · adults with dorsally displaced distal radius fractures
1 finding from 1 review
Overall number of people incurring one or more complications · adults with dorsally displaced distal radius fractures
1 finding from 1 review
Participants with 1 or more serious adverse events · patients with Guillain‐Barré syndrome
It is very uncertain whether brain‐derived neurotrophic factor changes participants with 1 or more serious adverse events compared with placebo (very low certainty).
1 finding from 1 review
Participants with 1 or more serious adverse events · patients with Guillain‐Barré syndrome
It is very uncertain whether cerebrospinal fluid filtration changes participants with 1 or more serious adverse events compared with plasma exchange (very low certainty).
1 finding from 1 review
Participants with 1 or more serious adverse events · patients with Guillain‐Barré syndrome
1 finding from 1 review
Participants with 1 or more serious adverse events · adults with severe Guillain‐Barré syndrome (GBS disability score > 2), within 2 weeks form onset
Eculizumab showed no clear difference in participants with 1 or more serious adverse events compared with placebo (low certainty).
1 finding from 1 review
Participants with 1 or more serious adverse events · patients with Guillain‐Barré syndrome
It is very uncertain whether interferon beta‐1a changes participants with 1 or more serious adverse events compared with placebo (very low certainty).
1 finding from 1 review
Gain of 15 letters or more of visual acuity at 6 months · macular oedema secondary to branch retinal vein occlusion
Anti‐VEGF probably leads to higher gain of 15 letters or more of visual acuity at 6 months compared with sham (moderate certainty).
1 finding from 1 review
BCVA: gain of 15 or more ETDRS letters · people with BRVO
Anti‐VEGF leads to higher gain of 15 letters or more of visual acuity compared with steroid (high certainty).
1 finding from 1 review
BCVA: gain of 15 or more ETDRS letters · people with BRVO
Anti‐VEGF probably leads to higher gain of 15 letters or more of visual acuity compared with laser (moderate certainty).
1 finding from 1 review
Victim empathy: attitudes to women Measured by: Attitude Towards Women Scale (15 items; scores range from 0 to 45; higher scores indicate more egalitarian attitudes towards women) · young people (aged 10 to 18 years old) with harmful sexual behaviour
1 finding from 1 review
Biochemically validated smoking cessation at the latest point in pregnancy (20 weeks' gestation or more) · Pregnant women who smoke
Nicotine replacement therapy may leads to higher biochemically validated smoking cessation at the latest point in… compared with control (low certainty).
1 finding from 1 review
Biochemically validated smoking cessation at the latest point in pregnancy (20 weeks' gestation or more) · Pregnant women who smoke
Bupropion showed no clear difference in biochemically validated smoking cessation at the latest point in… compared with control (low certainty).
1 finding from 1 review
Pain VAS. Scale from: 0 to 10; higher score = more pain · patients with Buerger's disease
1 finding from 1 review
People with one or more errors · healthcare workers
It is very uncertain whether procedures: donning and doffing with instructions changes people with one or more errors compared with without instruction (very low certainty).
1 finding from 1 review
Proportion of eyes with significant visual loss (loss of 2 or more lines from pretreatment BSCVA): 12 months · Adults with refractive errors
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Loss of 1 or more lines of BSCVA at 12 months post treatment · Adults with refractive errors
It is very uncertain whether wavefront‐guided LASIK changes proportion of eyes that had lost 1 or more lines of best… compared with wavefront‐guided PRK (very low certainty).
1 finding from 1 review
Proportion of eyes with significant visual loss (loss of 2 or more lines from pretreatment BSCVA): 12 months · Adults with refractive errors
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Proportion of eyes that had lost 1 or more lines of best spectacle‐corrected visual acuity (BSCVA) posttreatment:12 months ‐ Procedure PRK · Adults with refractive errors
Wavefront procedures showed no clear difference in proportion of eyes that had lost 1 or more lines of best… compared with conventional procedures (low certainty).
1 finding from 1 review